GSK3B and Alzheimer disease: In AD, tau hyperphosphorylation is suggested to be a pathogenic process caused by aberrant activation of several kinases, in particular cyclin-dependent protein kinase 5 (CDK5) and glycogen synthase kinase-3 beta (GSK3β), leading to phosphorylation of tau on pathogenic sites [46].